Pacira BioSciences, Inc. clinical trials

The registry lists 102 studies whose lead sponsor is Pacira BioSciences, Inc.. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 17, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 102. Browse all 102 →

• A Study to Assess Safety and Tolerability of PCRX-201 in Subjects With Painful Osteoarthritis of the KneeRecruitingNCT06884865Phase 2

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• Innovations in Genicular Outcomes RegistryRecruitingNCT05495334

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• Study to Evaluate the Pharmacokinetics and Safety of EXPAREL for Postoperative Analgesia in Subjects Undergoing Cardiac SurgeryRecruitingNCT06271265Phase 1

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• Study to Evaluate the Safety and Tolerability of FX201 in Patients With Osteoarthritis of the KneeActive, not recruitingNCT04119687Phase 1

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• Study to Assess the Efficacy and Safety of Iovera®° System in Subjects With Upper Extremity SpasticityActive, not recruitingNCT06340451Not applicable

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• ZILRETTA in Subjects With Shoulder OsteoarthritisActive, not recruitingNCT06269705Phase 3

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• A Study to Evaluate an Intra-Articular Injection of ZILRETTA Versus Triamcinolone Acetonide, Immediate Release in Subjects With Osteoarthritis of the HipTerminatedNCT06977568Phase 2

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• Phase 3, Sciatic Nerve Block With EXPAREL for Subjects Undergoing BunionectomyCompletedNCT05157841Phase 3

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• Phase 1, Dose Escalation Study to Evaluate of Safety, Pharmacokinetics and Pharmacodynamics of Liposomal Bupivacaine 13.3 Administered Via a Single Intrathecal Injection to Healthy VolunteersCompletedNCT05456490Phase 1

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• Phase 3 Adductor Canal Block With EXPAREL in Subjects Undergoing Primary Unilateral Total Knee ArthroplastyCompletedNCT05139030Phase 3

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• Study to Evaluate the Pharmacokinetics and Safety of EXPAREL Administered as a Pectoral Plane Block in Women Undergoing Breast AugmentationCompletedNCT04293809Phase 1

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• Study to Evaluate a Procedure for Intra-articular Injection of FX006 in Patients With Osteoarthritis of the HipCompletedNCT04065074Phase 2

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• Study Evaluating the Treatment of Occipital NeuralgiaCompletedNCT01753765Not applicable

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• Study to Compare Exposure of TA Following Administration of FX006 or TAcs in Patients With OA of the Shoulder or HipCompletedNCT03382262Phase 2

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• Study to Compare Exposure of TA Following Administration of Either FX006 or TAcs in Patients With Bilateral Knee OACompletedNCT03378076Phase 2

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• Study to Evaluate the Efficacy and Safety of FX006 in Patients With Glenohumeral Osteoarthritis or Shoulder Adhesive CapsulitisTerminatedNCT04160091Phase 2

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• Study to Characterize the Local Duration of Exposure From FX006 in Patients With Osteoarthritis of the KneeCompletedNCT02003365Phase 2

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• Cryo-Touch II for the Treatment of WrinklesCompletedNCT01167140Phase 2/3

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• Study Evaluating Treatment of Upper Limb Spasticity Using the Cryo-Touch III DeviceCompletedNCT01863901Not applicable

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• Study of FX006 vs Normal Saline in Patients With Osteoarthritis of the KneeCompletedNCT02116972Phase 2

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• A Prospective Study Evaluating the Treatment of Knee Osteoarthritis With the Cryo-Touch III DeviceCompletedNCT01704157Not applicable

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• Study to Evaluate the Efficacy and Safety of FX006 in Patients With Hip OsteoarthritisTerminatedNCT03793010Phase 3

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• Study to Assess the Safety of Repeat Administration of FX006 Administered to Patients With Osteoarthritis of the KneeCompletedNCT03046446Phase 3

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• A Randomized, Study to Evaluate the Iovera° Device in Treating Pain Associated With Total Knee ArthroplastyCompletedNCT02284113Not applicable

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• Study to Characterize the PK and Local Extent and Duration of Exposure From FX006 in Patients With OA of the KneeCompletedNCT02637323Phase 2

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• Study of FX005 for the Treatment of Pain in Patients With Osteoarthritis of the KneeCompletedNCT01291914Phase 1/2

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the KneeCompletedNCT02357459Phase 3

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• Study to Assess the Effects of FX006 on Blood Glucose in Patients With OA of the Knee and Type 2 DiabetesCompletedNCT02762370Phase 2

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• Pharmacokinetic and Pharmacodynamic Study of FX006 in Patients With Osteoarthritis of the KneeCompletedNCT01487200Phase 2

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• Study to Evaluate the Iovera° Device for Temporary Relief From Knee PainCompletedNCT02260921Not applicable

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• Study to Evaluate the Effect of FX006 on Synovial Inflammation in Patients With OA of the KneeCompletedNCT03529942Phase 3

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• Proof of Concept Study Comparing FX006 to Kenalog®-40 in Patients With Post-Traumatic Osteoarthritis of the KneeTerminatedNCT02468583Phase 2

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• Study of FX006 in Patients With Osteoarthritis of the KneeCompletedNCT01487161Phase 2

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• Probe Configuration and Time-Temperature Dose Ranging for Understanding of Skin Lesion EffectsCompletedNCT01681745Not applicable

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• Study in Pediatric Subjects Evaluating Pharmacokinetics and Safety of EXPARELCompletedNCT03485014Phase 1

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• Study to Evaluate Iovera®° in Adult Patients Undergoing Total Knee ArthroplastyTerminatedNCT04191031Not applicable

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• Study to Evaluate the Safety and Tolerability of FX301 in Patients Undergoing BunionectomyCompletedNCT04826328Phase 1

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• Efficacy and Safety of EXPAREL Versus Standard of Care (SoC) in Subjects Undergoing Elective Cesarean SectionCompletedNCT03853694Phase 4

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of EXPAREL, EXPAREL Admixed With Bupivacaine HCl vs. Bupivacaine HCl Administered as Combined Sciatic and Saphenous Nerve Blocks for Postsurgical Analgesia in Subjects Undergoing Lower Extremity SurgeriesCompletedNCT04518462Phase 3

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• Dose-Ranging Study for Prolonged Postoperative Analgesia in Subject Undergoing Total Knee ArthroplastyCompletedNCT00485693Phase 2

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• Phase 4 Study in Adult Subjects Undergoing Posterior Lumbar Spine SurgeriesTerminatedNCT03927911Phase 4

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• Phase 4, Controlled Study in Adult Subjects Undergoing Primary, 1-2 Level, Open Lumbar Spinal Fusion SurgeryTerminatedNCT03015961Phase 4

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• Intercostal Nerve Block With Liposome Bupivacaine in Subjects Undergoing Posterolateral ThoracotomyCompletedNCT01802411Phase 3

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• Safety and Pharmacokinetics Study of Redosing EXPAREL in Healthy VolunteersCompletedNCT02210247Phase 1

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• EXPAREL Administered by Infiltration Into the TAP for Prolonged Postsurgical Analgesia in Lower Abdominal SurgeriesTerminatedNCT01919190Phase 4

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• TAP-patients With Robotic Assisted Lap ProstatectomyCompletedNCT01582477Phase 4

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• Treatment With Iovera° for Total Knee Arthroplasty (TKA) Post-Operative PainCompletedNCT03327220Not applicable

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• Evaluation of Safety, Pharmacokinetics and Pharmacodynamics of EXPAREL® Administered Via a Single Intrathecal Injection to Healthy VolunteersTerminatedNCT04173611Phase 1

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• Evaluation of the Safety and Efficacy of EXPAREL When Administered Into the TAP in Subjects Undergoing Cesarean SectionTerminatedNCT02353754Phase 4

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc

• Pharmacokinetic Evaluation of EXPAREL in Adults Undergoing TonsillectomyCompletedNCT02199574Phase 4

  Sponsor listed in the registry: Pacira Pharmaceuticals, Inc